Your session is about to expire
← Back to Search
Tranexamic Acid for Breast Surgery Recovery
Study Summary
This trial is testing whether using a drug that prevents blood clot breakdown topically during surgery can reduce post-operative healing time and events such as bleeding and fluid accumulation.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2012 Phase 4 trial • 100 Patients • NCT00740116Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Are younger patients within the age limit of this research trial?
"The age requirement to participate in this study is between 18 and 80 years old."
Could I possibly take part in this research project?
"Eligible patients for this trial must be female, aged 18 or older, with scheduled plans for a bilateral mastectomy. In addition, all participants much be able to understand the study's informed consent form and sign it of their own accord."
Are there any available positions for candidates in this program?
"Yes, the information on clinicaltrials.gov suggests that this clinical trial is actively seeking candidates. The study was initially posted on 7/12/2022 and was last updated on 9/21/2022. The trial is admitting 30 patients across 2 sites."
Has the FDA cleared Experimental Breast for use?
"While there is some evidence to support the safety of Experimental Breast, it received a score of 2 because this is only supported by data from Phase 2 trials."
What is the total number of enrollees in this clinical trial?
"Yes, this is an active recruitment according to the information available on clinicaltrials.gov. The trial was first posted on 7/12/2022 and has been updated as recently as 9/21/2022. They are looking for 30 patients from 2 locations."
Share this study with friends
Copy Link
Messenger